Applied DNA Sciences (NASDAQ:APDN ) | WebDisclosure

Basculer en Français

8773	Companies
157607	Keywords
93099	Articles
84919	Press releases

Home
Companies
Applied DNA Sciences

BRIEF

published on 06/30/2025 at 15:05, 14 days 21 hours ago

Applied DNA Sciences se restructure pour se concentrer sur la fabrication d'ADN synthétique

Réduction Des Coûts Réduction Des Effectifs ADN Synthétique LineaRx Focus Produits Biothérapeutiques
BRIEF

published on 06/30/2025 at 15:05, 14 days 21 hours ago

Applied DNA Sciences Restructures to Focus on Synthetic DNA Manufacturing

Cost Reduction Biotherapeutics Workforce Reduction Synthetic DNA LineaRx Focus
PRESS RELEASE

published on 06/30/2025 at 15:00, 14 days 21 hours ago

Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx
Applied DNA Sciences, Inc. undergoes workforce reduction to focus on LineaRx synthetic DNA manufacturing. Ceases operations at Applied DNA Clinical Labs. Strategic decisions for growth and operational efficiency

Operational Efficiency Applied DNA Sciences Workforce Reduction LineaRx Synthetic DNA Manufacturing
BRIEF

published on 06/16/2025 at 15:05, 28 days 21 hours ago

Applied DNA Sciences relance ses appels trimestriels aux investisseurs

Résultats Financiers Biotechnologie Sciences Appliquées De L'ADN Technologies Basées Sur La PCR Appels Trimestriels Aux Investisseurs
BRIEF

published on 06/16/2025 at 15:05, 28 days 21 hours ago

Applied DNA Sciences to Restart Quarterly Investor Calls

Financial Results Biotechnology Applied DNA Sciences PCR-based Technologies Quarterly Investor Calls
PRESS RELEASE

published on 06/16/2025 at 15:00, 28 days 21 hours ago

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August
Applied DNA Sciences, Inc. announces the resumption of quarterly investor calls starting mid-August 2025, cancelling the June 17th call. The company focuses on PCR-based DNA technologies

Financial Results Biotechnology Applied DNA Sciences PCR-based DNA Technologies Investor Calls
BRIEF

published on 03/26/2025 at 14:05, 3 months 19 days ago

Applied DNA Submits Bird Flu Test for New York State Approval

DNA Technologies New York State Approval H5 Bird Flu Laboratory-developed Test CDC Recommendations
BRIEF

published on 03/26/2025 at 14:05, 3 months 19 days ago

Applied DNA soumet un test de dépistage de la grippe aviaire à l'approbation de l'État de New York

Approbation De L'État De New York Technologies De L'ADN Grippe Aviaire H5 Test Développé En Laboratoire Recommandations Du CDC
PRESS RELEASE

published on 03/26/2025 at 14:00, 3 months 19 days ago

Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test
Applied DNA Sciences' ADCL seeks NYSDOH approval for PCR-based assay to detect H5 bird flu, leveraging PCR-based DNA technologies. Development initiated due to health concerns

Applied DNA Sciences NYSDOH Approval ADCL H5 Bird Flu PCR-based Assay
BRIEF

published on 03/12/2025 at 13:05, 4 months 2 days ago

Applied DNA Implements 1-for-50 Reverse Stock Split

Reverse Stock Split Stock Trading Nasdaq Compliance Applied DNA Sciences Share Adjustment

1 2 ... 7

Accesswire

Published on 07/15/2025 at 12:00, 30 minutes ago

Primary Hydrogen Launches Phase 2 Hydrogen Sampling at Crooked Amphibolite, Coquihalla, And Cogburn Projects In British Columbia
Published on 07/15/2025 at 09:05, 3 hours 25 minutes ago

Nano One Selected to Join U.S. ALTA and Strengthen North American Battery Supply Chain
Published on 07/15/2025 at 09:01, 3 hours 29 minutes ago

Star Copper Provides Site Visit Update of Ongoing Drill Campaign in British Columbia's Golden Triangle
Published on 07/15/2025 at 07:10, 5 hours 20 minutes ago

SAINT BELLA Debuts in the U.S., Setting a New Standard for Postpartum Care
Published on 07/15/2025 at 03:00, 9 hours 30 minutes ago

Forte Group Announces Initiatives to Strengthen Financial Position

View all ACCESSWIRE

EQS Group

Published on 07/15/2025 at 12:14, 16 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 07/15/2025 at 12:12, 18 minutes ago

Redcare Pharmacy’s CardLink solution for e-Rx redemption extended by gematik, enabling a smooth transition to the next generation technology.
Published on 07/15/2025 at 11:41, 49 minutes ago

EQS-Adhoc: Redcare Pharmacy’s CardLink solution extended by gematik.
Published on 07/15/2025 at 10:39, 1 hour 51 minutes ago

CPI Property Group announces the invitation to holders of its outstanding Senior Unsecured Green Notes due 7 May 2029 to tender the Notes for purchase by the Company for cash
Published on 07/15/2025 at 10:00, 2 hours 30 minutes ago

Original-Research: Samara Asset Group PLC (von GBC AG): BUY

Les Echos

Published on 07/15/2025 at 08:16, 4 hours 14 minutes ago

CDA - New PSD at Pralognan-la-Vanoise
Published on 07/15/2025 at 08:15, 4 hours 15 minutes ago

CDA - Nouvelle DSP à Pralognan-la-Vanoise
Published on 07/15/2025 at 07:00, 5 hours 30 minutes ago

Biophytis s’associe à Lynx Analytics dans le domaine de l’IA pour accélérer la découverte de médicaments contre la sarcopénie
Published on 07/15/2025 at 07:00, 5 hours 30 minutes ago

Biophytis Partners in AI with Lynx Analytics to Accelerate Drug Discovery for Sarcopenia
Published on 07/11/2025 at 18:00, 3 days 18 hours ago

THERMADOR GROUPE : 2025 half year turnover

View all LES ECHOS COMFI WIRE